Rebecca Bruner

Statistics

Publications

Citations

218

H-Index

Active since

2003

Affiliations

Theravance Biopharma (United States)(Current)

Rebecca Bruner is an author at Theravance Biopharma (United States) specializing in hematology, hematologic malignancy therapy, and platelet-derived growth factor inhibition.

Publications per year

2003–2003

Publications

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

John H. Griffin, Joey Leung, Rebecca Bruner et al. · Proceedings of the National Academy of Sciences · 2003 · 202 citations · Full text

Life Sciences, Genetics, Hematology +14

An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies

Thomas C. Shea, Rebecca Bruner, Joseph M. Wiley et al. · Biology of Blood and Marrow Transplantation · 2003 · 16 citations

Medicine, Hematology, Oncology +17

1–2 of 2